Home > Video > Multiple myeloma: New therapy against relapse approved

Multiple myeloma: New therapy against relapse approved

Multiple myeloma: New therapy against relapse approved

Multiple myeloma, AIFA approved the two triplet therapies with belantamab mafodotin, increasing disease-free survival by three years. In ten months, approximately 400 patients have already been treated thanks to dedicated access programs. A meeting in Turin will illustrate the impact of the new therapy...

di Posted on

© All rights reserved

Multiple myeloma, AIFA approved the two triplet therapies with belantamab mafodotin, which increase disease-free survival by three years. In ten months, approximately 400 patients have already been treated thanks to dedicated access programs. A meeting in Turin to illustrate the real-life impact of the new therapy.

https://www.youtube.com/watch?v=Gz4r2mNWHAc

Continue on the app The news of your city, in real time.
Open in app